Research Project
DATA-INDUCTOR brings together a network of experts in the field of safety and efficacy testing,
model development and genetic immune-oncology to develop the needed preclinical tools for
pharma companies. DATA-INDUCTOR consortium will support the design, production and testing
of biological drugs using immunologically relevant human-based models. We will implement ISO standardized solutions to achieve GLP level safety/efficacy testing for selected assays and tools.
Data-driven predictive computational models will be developed to enable prediction of drug
responses and identification of novel targets. These will enable faster and more efficient translation of preclinical findings into clinical success.
DATA-INDUCTOR is part of Orion’s Veturi
ecosystem activities (WP1 and WP2), as one of the key actions to improve the research
ecosystem capabilities in Finland. Consortium is also part of HEALTH 360 Finland.
News
5.3.2026
Armored NK Cell Therapies Gain Global Momentum
The global field of cell and gene therapy is rapidly evolving toward next-generation “armored” immune cell therapies designed to overcome tumor-mediated immunosuppression. A recent example is…